by Steve Kanters, Marco Vitoria, Meg Doherty et al.
The Lancet HIV, Vol. 3, No. 11, e510–e520, November 2016
The efficacy and safety of antiretroviral therapy (ART) has substantially improved with the introduction of newer drug classes of antiretrovirals that are now available to patients and HIV care providers. Their improved tolerance could be part of a larger solution to improve retention, which is a challenge, particularly in low-income and middle-income country settings.